Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ABL1 | P00519 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | IDE | P14735 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | HLCS | P50747 | 6/20 | 0.56 |
| ▸ | CA12 | O43570 | 5/20 | 0.43 |
| ▸ | CA1 | P00915 | 5/20 | 0.43 |
| ▸ | CA2 | P00918 | 5/20 | 0.43 |
| ▸ | CA9 | Q16790 | 5/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1936659 | 0.86 | TDP1 (0.65) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL487045 | 0.85 | TDP1 (0.68) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL8534380 | 0.85 | TDP1 (0.64) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL425273 | 0.84 | TDP1 (0.67) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL6036962 | 0.83 | TDP1 (0.65) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL6803047 | 0.83 | HLCS (0.62) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL3827268 | 0.83 | TDP1 (0.58) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL629531 | 0.82 | TDP1 (0.74) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL875085 | 0.82 | TDP1 (0.64) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL5592430 | 0.82 | TDP1 (0.64) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6667387-B1 | Immunodominant epitope identified in the gp41 region of the HIV- 1 strain Ant70; in vitro determination of HIV-1-specific antibodies. | N.V. INNOGENETICS S.A. (BE) | 2003-12-23 | — | — | US | disclosed |
| US-6355616-B1 | FUNGICIDE OLIGOPEOTIDES | XOMA (US) TECHNOLOGY LTD. | 2002-03-12 | — | — | US | disclosed |
| US-6210903-B1 | AMINO ACID SEQUENCE WHICH IS OPTIONALLY MODIFIED AND BIOTINYLATED | N. V. INNOGENETICS S. A. (BE) | 2001-04-03 | — | — | US | disclosed |
| WO-2001000671-A1 | DERIVATIVE COMPOUNDS | XOMA TECHNOLOGY LTD. (US) | 2001-01-04 | — | — | WO | disclosed |
| US-5891640-A | USE OF THIS PEPTIDE, PARTICULARLY WHEN BIOTINYLATED IN THE FORM OF COMPLEXES OF STREPTAVIDIN-BIOTINYLATED PEPTIDES OR OF AVIDIN-BIOTINYLATED PEPTIDES, FOR THE IN VITRO DETERMINATION OF HIV-1-SPECIFIC ANTIBODIES | N.V. INNOGENETICS S.A. (BE) | 1999-04-06 | — | — | US | disclosed |
| EP-0589004-A1 | PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM | N.V. INNOGENETICS S.A. (BE) | 1994-03-30 | — | — | EP | disclosed |